What is NDC 72065-121?

72065-121 is the product NDC for Gvoke HypoPen 1 mg Auto-Injector, Glucagon 1 mg/.2mL injection, solution, listed with the FDA by Xeris Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Gvoke HypoPen 1 mg Auto-Injector (Glucagon injection, solution).

Xeris Pharmaceuticals, Inc., NDC labeler code 72065. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gvoke HypoPen 1 mg Auto-Injector?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gvoke HypoPen 1 mg Auto-Injector NDC 72065-121

NDC codes

FDA NDC Directory

Product NDC (as listed)72065-121Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72065-0121Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72065-121-11	7206501211172065012111	1 POUCH in 1 CARTON (72065-121-11) / 1 SYRINGE, PLASTIC in 1 POUCH / .2 mL in 1 SYRINGE, PLASTICMarketed from Sep 10, 2019
72065-121-12	7206501211272065012112	2 POUCH in 1 CARTON (72065-121-12) / 1 SYRINGE, PLASTIC in 1 POUCH / .2 mL in 1 SYRINGE, PLASTICMarketed from Sep 10, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gvoke HypoPen 1 mg Auto-InjectorSuffix: 1 mg Auto-Injector
Generic name (nonproprietary): glucagon injection, solution
Active ingredients: Glucagon — 1 mg/.2mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Xeris Pharmaceuticals, Inc.NDC labeler code 72065
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 212097
Marketing start: Sep 10, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Decreased GI Motility (Physiologic effect)Decreased GI Smooth Muscle Tone (Physiologic effect)Decreased Glycolysis (Physiologic effect)Increased Gluconeogenesis (Physiologic effect)Increased Glycogenolysis (Physiologic effect)
Identifiers: Product ID 72065-121_050d2f58-d6e7-4cc6-8b27-f2f19158a36cSPL ID 050d2f58-d6e7-4cc6-8b27-f2f19158a36c
Pharmacologic class: Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472065012111 followed by a unit qualifier and the quantity

Package 72065-0121-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 72065-121

What is NDC 72065-121?: 72065-121 is the product NDC for Gvoke HypoPen 1 mg Auto-Injector, Glucagon 1 mg/.2mL injection, solution, listed with the FDA by Xeris Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gvoke HypoPen 1 mg Auto-Injector (Glucagon injection, solution).
What is the active ingredient?: Glucagon.
Who is the labeler?: Xeris Pharmaceuticals, Inc., NDC labeler code 72065. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gvoke HypoPen 1 mg Auto-Injector?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 212097

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 212097
Product	Strength	Form · route	Labeler	Product NDC
Gvoke HypoPen 0.5 mg Auto-Injectorglucagon injection, solution	Glucagon .5 mg/.1mL	Injection, SolutionSubcutaneous	Xeris Pharmaceuticals, Inc.	72065-120
Gvoke Kitglucagon injection, solution	Glucagon 1 mg/.2mL	Injection, SolutionSubcutaneous	Xeris Pharmaceuticals, Inc.	72065-140
Gvoke PFS 1 mg Pre-filled Syringeglucagon injection, solution	Glucagon 1 mg/.2mL	Injection, SolutionSubcutaneous	Xeris Pharmaceuticals, Inc.	72065-131
Gvoke VialDxglucagon injection	Glucagon 1 mg/.2mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-2901

Gvoke HypoPen 1 mg Auto-Injector (Glucagon injection, solution) NDC 72065-121